Search   
MSDS  : Escin
CAS  : 6805-41-0
SYNONYMS  : * A-4700 * Aescin * Aescusan * Amorphous aescin * Escina * Reparilu
*** CHEMICAL IDENTIFICATION ***

RTECS NUMBER : KF6296000
CHEMICAL NAME : Escin
CAS REGISTRY NUMBER : 6805-41-0
OTHER CAS REGISTRY NOS. : 1394-90-7
LAST UPDATED : 199609
DATA ITEMS CITED : 15
MOLECULAR FORMULA : C54-H84-O23
MOLECULAR WEIGHT : 1101.38
COMPOUND DESCRIPTOR : Drug
Reproductive Effector
Natural Product
SYNONYMS/TRADE NAMES :
* A-4700
* Aescin
* Aescusan
* Amorphous aescin
* Escina
* Reparilu

*** HEALTH HAZARD DATA ***

** ACUTE TOXICITY DATA **

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 833 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 8,118,1974

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 10150 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 8,118,1974

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 150 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 8,118,1974

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 1600 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
BCFAAI Bollettino Chimico Farmaceutico. (Societa Editoriale Farmaceutica,
Via Ausonio 12, 20123 Milan, Italy) V.33- 1894- Volume(issue)/page/year:
115,272,1976

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 165 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 8,118,1974

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 6700 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo,
Japan) Volume(issue)/page/year: 6,APP-2,1982

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 38590 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 8,118,1974

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 2 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
BCFAAI Bollettino Chimico Farmaceutico. (Societa Editoriale Farmaceutica,
Via Ausonio 12, 20123 Milan, Italy) V.33- 1894- Volume(issue)/page/year:
115,272,1976

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rabbit
DOSE/DURATION : 2500 mg/kg
TOXIC EFFECTS :
Liver - hepatitis (hepatocellular necrosis), diffuse
Kidney, Ureter, Bladder - changes in tubules (including acute renal failure,
acute tubular necrosis)
Blood - other hemolysis with or without anemia
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag,
Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951-
Volume(issue)/page/year: 10,280,1960

** OTHER MULTIPLE DOSE TOXICITY DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 9600 mg/kg/32D-C
TOXIC EFFECTS :
Related to Chronic Data - death
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 9,1270,1975

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 3 gm/kg/30D-C
TOXIC EFFECTS :
Nutritional and Gross Metabolic - changes in sodium
Biochemical - Enzyme inhibition, induction, or change in blood or tissue
levels - transaminases
Related to Chronic Data - death
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 9,1270,1975

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rabbit
DOSE/DURATION : 33 mg/kg/30D-I
TOXIC EFFECTS :
Blood - changes in erythrocyte (RBC) count
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag,
Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951-
Volume(issue)/page/year: 10,280,1960

** REPRODUCTIVE DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE : 36 mg/kg
SEX/DURATION : female 7-16 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
BLLIAX Bratislavske Lekarske Listy. (PNS-Ustredna Expedicia a Dovoz Tlace,
Gottwaldovo nam. 6, 813 81 Bratislava, Czechoslovakia) V.1- 1921-
Volume(issue)/page/year: 87,76,1987

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rabbit
DOSE : 325 mg/kg
SEX/DURATION : female 6-18 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - extra-embryonic structures
(e.g., placenta, umbilical cord)
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 9,1227,1975

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rabbit
DOSE : 81250 mg/kg
SEX/DURATION : female 6-18 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 9,1227,1975

*** END OF RECORD ***
Search More   
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
NAMECAS
Erythromycin,9-deoxo-9-(((2-methylphenyl)sulfonyl)amino)-, (9S)- 61066-22-6
Erythromycin,9-deoxo-9-(((4-methylphenyl)sulfonyl)amino)-, (9S)- 56998-46-0
Erythromycin,9-deoxo-9-(((4-((1-oxopropyl)amino)phenyl)sulfonyl)amino)-, (9S)- 61066-21-5
Erythromycin, 12-deoxy- 527-75-3
Erythromycin,1,4-dihydro-1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylate 167029-45-0
Erythromycin, 2'-ester withN-(2-mercaptopropionyl)glycine 2-thiophenecarboxylate 167029-45-0
Erythromycin, 8-fluoro- 82664-20-8
Erythromycin, 2'-(2-furancarboxylate) 60847-79-2
Erythromycin, 2'-(3-(2-furyl)acrylate) 60847-78-1
2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione, 3-formyl-5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate, O-heptyloxime 41776-57-2
Erythromycin, glucoheptonate (11) 23067-13-2
Erythromycin, hydrochloride 14271-02-4
Erythromycin, 9-O-((2-methoxyethoxy)methyl)oxime 80214-83-1
Erythromycin, 6-O-methyl- 81103-11-9
Erythromycin, 2'-(5-nitro-2-furancarboxylate) 60847-76-9
Erythromycin, 2'-((5-nitro-2-furyl)acrylate) 60847-77-0
Erythromycin palmitate 111639-04-4
Erythromycin, d-pantothenate 111639-04-4
Erythromycin, 2'-propionate 134-36-1
Erythromycin, propionate (ester), compd. withmonododecyl sulfate (1:1) 3521-62-8
2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione, 3-formyl-5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate, O-(hept-2-yl) oxime 41776-73-2
Erythromycin, stearate (salt) 643-22-1
Erythromycin, sulfamate (salt) 24380-21-0
Erythronic acid, 4-(6-amino-9H-purin-9-yl)-4-deoxy-,D- 23918-98-1
Erythropalum populifolium (Arn.)Mast., extractSUBSTANCE DEFINITION :Plant belonging to the family OlacaceaeREFERENCE :IJEBA6 Indian Journal of Experimental Biology. (Publications & InformationDirectorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963-Volume(issue)/page/year: 28,619,1990 23918-98-1
Erythrophleum guineense (leaves)SUBSTANCE DEFINITION :Leaves of large trees belonging to the family CaesalpinaceaeREFERENCE :RVTSA9 Research in Veterinary Science. (British Veterinary Assoc., 7Mansfield St., London W1M OAT, UK) V.1- 1960- Volume(issue)/page/year:28,112,1980 23918-98-1
Erythropoietin 11096-26-7
1-165-Erythropoietin (human clone lambda HEPOFL13protein moiety), glycoform alpha 113427-24-0
1-165-Erythropoietin (human clone lambda HEPOFL13protein moiety), glycoform beta 122312-54-3
1-165-Erythropoietin (human clone lambda hepofl13protein moity), glycoform-gamma 130455-76-4
D-Erythrose, tri-O-acetyl-, p-nitrophenylhydrazine 54420-06-3
2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione, 3-formyl-5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate, O-(hept-3-yl) oxime 41887-57-4
Erythroxylum kunthianum Kurz, extract excluding rootSUBSTANCE DEFINITION :Indian plant belonging to the family ErythroxylaceaeREFERENCE :IJEBA6 Indian Journal of Experimental Biology. (Publications & InformationDirectorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963-Volume(issue)/page/year: 26,883,1988 41887-57-4
Escin 6805-41-0
alpha-Escin 66795-86-6
beta-Escin 11072-93-8
beta-Escin, monosodium salt 64156-26-9
Escin, sodium salt 20977-05-3
Escin, triethanolamine salt 102505-08-8
Espinomycin B 102534-94-1
Essential phospholipidsSUBSTANCE DEFINITION :Chemically defined as diglyceride esters of choline phosphoric acid with apredominant content of unsaturated fatty acidsREFERENCE :OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,Sendai 980-91, Japan) V.1- 1967- 102534-94-1
Estra-1,4-diene-3,17-dione, 10-hydroxy- 549-03-1
2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione, 3-formyl-5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate, O-(hex-2-enyl) oxime 63950-95-8
Estra-1,4-diene-3,17-dione, 10-hydroxy-, acetate 4147-12-0
Estra-1,4-dien-3-one, 10-beta-chloro-17-beta-hydroxy- 4147-12-0
Estra-1,4-dien-3-one, 10,17-beta-dihydroxy-,10-acetate 4147-11-9
Estra-1,4-dien-3-one, 10,19-dihydroxy-, 10-acetate 4147-11-9
Estra-4,9-dien-3-one,11-(4-(dimethylamino)phenyl)-17-hydroxy-17-(3-hydroxy-1-propenyl)-, (11-beta,17-beta,17(Z))- 97747-88-1
Estra-4,9-dien-3-one,11-(4-(dimethylamino)phenyl)-17-hydroxy-17-(3-hydroxypropyl)-, (11-beta,13-alpha,17-alpha)- 96346-61-1
Estra-4,9-dien-3-one,11-(4-(dimethylamino)phenyl)-17-hydroxy-17-(1-propynyl)-, (11-beta, 17-beta)- 84371-65-3

Free MSDS Search ( Providing 250,000+ Material Properties )
Chemcas.com| Ads link:todaystock.net